Stay updated on Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial

Sign up to get notified when there's something new on the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.8.0 to v3.8.1.
    Difference
    0.0%
    Check dated 2026-11-18T01:43:30.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The NCT02873962 record is now accessible, with details on the ovarian cancer study’s treatment arms, eligibility criteria, locations, and outcome measures. The record also includes posted results and a study protocol document.
    Difference
    68%
    Check dated 2026-11-10T22:53:22.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:01:00.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The clinical trial record is no longer displayed; the page now shows a 403 Forbidden error with a Home link.
    Difference
    21%
    Check dated 2026-10-27T23:05:55.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    A sitewide notice about NIH’s terminology transition appears above the page, and the site revision advances from v3.7.1 to v3.7.2. The study record area still shows a 403 error.
    Difference
    1%
    Check dated 2026-10-20T22:24:14.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-06T22:25:51.000Z thumbnail image

Stay in the know with updates to Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page.